FUZAPLADIB
UNII 03TE67E8IR

Substance Identification & Data

This profile provides standardized clinical and technical data for Fuzapladib, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 03TE67E8IR.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 141283-87-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
03TE67E8IR
CAS Registry Number
141283-87-6
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
FUZAPLADIB
Official standardized name for this substance within the FDA UNII nomenclature system.
Molecular Formula
03TE67E8IR
The specific atomic composition represented as a molecular structure string.
InChIKey
C15H20F3N3O3S
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
TUWCZRFHNIOVTC-UHFFFAOYSA-N
Line notation for describing the chemical structure and connectivity of atoms.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
PubChem CID
Unique identification number in the NCBI database of chemical substances.
INN ID
10971
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
C1(CCCCC1)C(=O)Nc2c(ncc(c2)C(F)(F)F)NS(=O)(=O)CC

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Fuzapladib. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

FUZAPLADIB

Common Names & Synonyms

FUZAPLADIB [INN]
IS-741

Systematic Nomenclature

CYCLOHEXANECARBOXAMIDE, N-(2-((ETHYLSULFONYL)AMINO)-5-(TRIFLUOROMETHYL)-3-PYRIDINYL)-
N-(2-(ETHANESULFONAMIDO)-5-(TRIFLUOROMETHYL)PYRIDIN-3-YL)CYCLOHEXANECARBOXAMIDE